Retrophin Becomes Oversold (RTRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of Retrophin, Inc. ( RTRX) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $18.04 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 54.1. A bullish investor could look at RTRX's 29.7 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of RTRX shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Retrophin, Inc. 1 Year Performance Chart

Looking at the chart above, RTRX's low point in its 52 week range is $11.60 per share, with $24.57 as the 52 week high point — that compares with a last trade of $18.19.

If you liked this article you might like

Martin Shkreli, "The Most Hated Man in America," Was Just Convicted on 3 Counts of Securities Fraud

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

Juror Selection In Martin Shkreli Case Drags Into a Third Day

First Amendment Needs to 'Take a Backseat' in Pharma Bro Trial: Lawyer

Potential Jurors Lambaste 'Pharma Bro' Shkreli as Judge Calls 180 People to Fill Just 18 Spots